REVA Medical, LLC. is a leader in bioresorbable polymer technologies for vascular applications. REVA's lead product, Fantom Encore, is a drug-eluting bioresorbable scaffold for the treatment of coronary artery disease. Fantom Encore is made from Tyrocore, REVA’s proprietary tyrosine derived polymer. Unlike metallic stents, Fantom Encore is designed support the artery through the healing process, and then disappear (or “resorb”) from the body in order to restore natural function to the artery. Learn more at www.revamedical.com.
Location: United States, California, San Diego
Employees: 51-200
Total raised: $45M
Founded date: 1998
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 20.08.2022 | Series B | $45M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 11.08.2022 | Reva Medical Raises $45M Series B Financing to support their... | - | connect.or... |
| 11.08.2022 | Reva Medical Raises $45M in Series B Equity Financing | Reva Medical, LLC, a San Diego, CA-based leader in bioresorbable polymer technologies for vascular a... | finsmes.co... |
| 27.05.2022 | REVA MEDICAL ANNOUNCES FINAL 5 YEAR RESULTS FOR IT’S FANTOM ... | SAN DIEGO, CA, UNITED STATES, May 27, 2022 /EINPresswire.com/ -- REVA Medical, LLC. (“REVA” or the “... | einpresswi... |
| 25.06.2021 | Roth Capital Partners to Host a Virtual Healthcare Private C... | NEWPORT BEACH, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Roth Capital Partners (... | marketscre... |
| - | Massachusetts-based device company raises $34.76 million to ... | GI Dynamics, Inc., a Lexington, Mass.-based company known for its EndoBarrier Therapy, which it clai... | medcitynew... |